Brian Halak BSE, PhD

Brian is currently a member of the Advisory Board for the Department of BioEngineering of the University of Pennsylvania, an advisor to Elm Street Ventures, and a director on the board of Life Sciences Pennsylvania.
Prior to Domain, Brian was an associate with Advanced Technology Ventures where he participated in the firm’s investments in Plexxikon, Percardia and Emphasys. Previous to that, he was a consultant at the Wilkerson Group, where he developed strategy for pharmaceutical and medical device companies. Brian received his BSE in bioengineering from University of Pennsylvania and his Ph.D. in immunology from Thomas Jefferson University.